Back to Browse Journals » Journal of Pain Research » Volume 3

An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy

Authors William Eardley, Cory Toth

Published Date April 2010 Volume 2010:3 Pages 33—49

DOI http://dx.doi.org/10.2147/JPR.S8675

Published 1 April 2010

William Eardley, Cory Toth

Department of Clinical Neurosciences and the University of Calgary, Calgary, AB, Canada

Abstract: Although many therapies are used in the management of neuropathic pain (NeP) due to polyneuropathy (PN), few comparison studies exist. We performed a prospective, non-randomized, unblended, efficacy comparison of the serotonin-norepinephrine reuptake inhibitor venlafaxine, as either monotherapy or adjuvant therapy, with a first-line medication for NeP, gabapentin, in patients with PN-related NeP. VAS pain scores were assessed after 3 and 6 months in intervention groups and in a cohort of patients receiving no pharmacotherapy. In a total of 223 patients, we analyzed pain quantity and quality (visual analogue scale [VAS] score, Brief Pain Inventory [BPI]), quality of life and health status measures [EuroQol 5 Domains, EQ-5D], Medical Outcomes Sleep Study Scale [MOSSS], Hospital Anxiety and Depression Scale [HADS] and Short Form 36 Health Survey [SF-36]) after 6 months of therapy. Significant improvements in VAS pain scores occurred for all treatment groups after 6 months. Improvements in aspects of daily life and anxiety were identified in all treatment groups. Our data suggest that monotherapy or adjuvant therapy with venlafaxine is comparable to gabapentin for NeP management. We advocate for head-to-head, randomized, double-blinded studies of current NeP therapies.

Keywords: peripheral neuropathy, neuropathic pain, pharmacotherapy, venlafaxine, gabapentin

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

The importance of catastrophizing for successful pharmacological treatment of peripheral neuropathic pain

Toth C, Brady S, Hatfield M

Journal of Pain Research 2014, 7:327-338

Published Date: 24 June 2014

Readers of this article also read:

Alternative ultraviolet A lamp for corneal collagen crosslinking

Diaz-Llopis M, Salom D, Garcia-Delpech S, Udaondo P, Garcia-Pous M

Clinical Ophthalmology 2013, 7:557-559

Published Date: 16 March 2013

Advances in dental veneers: materials, applications, and techniques

Pini NP, Aguiar FHB, Lima DAN, Lovadino JR, Terada RS, Pascotto RC

Clinical, Cosmetic and Investigational Dentistry 2012, 4:9-16

Published Date: 10 February 2012

Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction

Paul A, Nayan M, Khan AA, Shum-Tim D, Prakash S

International Journal of Nanomedicine 2012, 7:663-682

Published Date: 8 February 2012

Advances in the diagnosis and management of lymphoma

Word ZH, Matasar MJ

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:29-55

Published Date: 3 February 2012

A more rapid approach to systematically assessing published associations of genetic polymorphisms and disease risk: type 2 diabetes as a test case

Cho AH, Jiang X, Mann DM, Kawamoto K, Robinson TJ, Wang N, McCarthy JJ, Woodward M, Ginsburg GS

Comparative Effectiveness Research 2012, 2:1-20

Published Date: 26 January 2012

Analgesic effects of intra-articular botulinum toxin Type B in a murine model of chronic degenerative knee arthritis pain

Stephanie Anderson, Hollis Krug, Christopher Dorman, et al

Journal of Pain Research 2010, 3:161-168

Published Date: 6 September 2010

Arterial Stiffness and Pharmacological Interventions – The TRanscend Arterial stiffNess Substudy (TRANS study)

Jirar Topouchian, Ramzi El Feghali, Bruno Pannier, Shuyu Wang, Feng Zhao, Karel Smetana, Koon Teo, Roland Asmar

Vascular Health and Risk Management 2007, 3:381-388

Published Date: 4 October 2007